Directorate Change
ASTRAZENECA PLC: BOARD CHANGE
At AstraZeneca PLC's Annual General Meeting on 28 April 2011, as usual and in accordance with its Articles of Association, all of the Directors are retiring. The biographical details of each Director presenting himself or herself for election or re-election are set out in the Notice of AGM 2011 and Shareholders' Circular, which is available online at astrazeneca.com/noticeofmeeting2011.
Jane Henney will not present herself for re-election this year and will leave the Board at the close of the AGM. Commenting on the change, Louis Schweitzer, Chairman of the Board, said: "Jane was first elected in 2001, since when she has made a significant contribution to the Board's work and the Company's success. She has served as a member of the Audit Committee, the Nomination and Governance Committee and the Science Committee. Jane's dedication, judgement, insightful comments and strong support have been appreciated by all colleagues who have had the pleasure of working with her. On behalf of the Board, we thank her for her service to AstraZeneca and warmly wish her well as she leaves us."
A C N Kemp
Company Secretary
14 March 2011
This information is provided by RNS